Stockholm - Delayed Quote • SEK
Boule Diagnostics AB (publ) (BOUL.ST)
At close: 5:29 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
51,377.00
51,377.00
-11,353.00
43,284.00
75,239.00
Investing Cash Flow
-82,714.00
-82,714.00
-74,961.00
-56,370.00
-46,006.00
Financing Cash Flow
-25,506.00
-25,506.00
140,550.00
15,754.00
-14,881.00
End Cash Position
37,281.00
37,281.00
96,904.00
38,183.00
32,989.00
Capital Expenditure
-82,713.00
-82,713.00
-74,961.00
-56,370.00
-46,007.00
Issuance of Capital Stock
--
--
149,507.00
--
--
Free Cash Flow
-31,336.00
-31,336.00
-86,314.00
-13,086.00
29,232.00
12/31/2020 - 6/23/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
688389.SS Shenzhen Lifotronic Technology Co., Ltd.
19.75
+4.28%
EKF.L EKF Diagnostics Holdings plc
27.60
-0.72%
CEVI.ST CellaVision AB (publ)
220.50
-3.92%
300760.SZ Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
288.80
+1.30%
QTRX Quanterix Corporation
15.56
-0.19%
CHEMM.CO ChemoMetec A/S
286.60
+1.49%
BIO Bio-Rad Laboratories, Inc.
275.94
+0.12%
PACB Pacific Biosciences of California, Inc.
1.4700
+6.52%